arrow
A

Adrienn Vágner

scanomed ltd.
H指数:12
被引数:401

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Enhanced Tumor-to-Background Contrast with [52Mn]Mn-BPPA-Bevacizumab VEGF-Targeted Immuno-PET in Cervical Cancer

增强型肿瘤-背景对比度:[52Mn]Mn-BPPA-Bevacizumab VEGF靶向免疫PET在宫颈癌中的应用

2026-03-300
OAAI
Evaluation of the therapeutic efficacy of 213Bi-labelled DOTA-conjugated alpha-melanocyte stimulating hormone peptide analogues in melanocortin-1 receptor positive preclinical melanoma model

213bi-dota标记的 α-黑素细胞刺激素肽类似物在melanocortin-1受体阳性临床前黑色素瘤模型中的疗效评价

2023-09-012
OAAI
In Vivo evaluation of newly synthesized 213Bi-conjugated alpha-melanocyte stimulating hormone (α-MSH) peptide analogues in melanocortin-1 receptor (MC1-R) positive experimental melanoma model
2023-05-015
OAAI
Synthesis and characterization of a novel [52Mn]Mn-labelled affibody based radiotracer for HER2+targeting
2023-01-014
PRE